Alaunos Therapeutics (TCRT) Short term Debt (2021 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Short term Debt came in at $11.0 million in Q1 2023, down 21.48% YoY from $14.0 million in Q1 2022, and down 34.46% on a QoQ basis from $16.8 million in Q4 2022.
Alaunos Therapeutics (TCRT) Short term Debt (2021 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 3 years of Short term Debt data on file, last reported at $11.0 million in Q1 2023.
- Quarterly Short term Debt fell 21.48% year-over-year to $11.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $11.0 million (down 21.48% YoY) and the FY2022 annual result came in at $16.8 million, up 113.08% from the prior year.
- Short term Debt slipped to $11.0 million in Q1 2023, from $16.8 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $22.7 million in Q3 2022 to a low of $7.9 million in Q4 2021.
- A 3-year average of $14.9 million and a median of $14.0 million in 2022 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2022 — Short term Debt soared 113.08% — and 2023, when it declined 21.48%.
- Tracing TCRT's Short term Debt over 3 years: stood at $7.9 million in 2021, then soared by 113.08% to $16.8 million in 2022, then plunged by 34.46% to $11.0 million in 2023.
- The last three Short term Debt figures came in at $11.0 million (Q1 2023), $16.8 million (Q4 2022), and $22.7 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 10.99 Mn |
| Dec 31, 2022 | 16.77 Mn |
| Sep 30, 2022 | 22.67 Mn |
| Jun 30, 2022 | 20.05 Mn |
| Mar 31, 2022 | 13.99 Mn |
| Dec 31, 2021 | 7.87 Mn |
| Sep 30, 2021 | 12.04 Mn |